| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/08/2008 | CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 01/08/2008 | CA2324028C Retroviral packaging cell line |
| 01/08/2008 | CA2306824C Encapsulation method |
| 01/08/2008 | CA2291983C Ligand-mediated immunofunctional hormone binding protein assay method |
| 01/08/2008 | CA2272261C Reducing agent for reductive alkylation of glycopeptide antibiotics |
| 01/08/2008 | CA2218145C Method of treating dilated cardiomyopathy |
| 01/08/2008 | CA2203631C Cyclic peptide obtained from actinomyces s. nobilis useful as therapeutic agent |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/08/2008 | CA2145826C Lipopeptide derivatives, a process for their preparation and their use |
| 01/08/2008 | CA2116179C Verotoxin pharmaceutical compositions and medical treatments therewith |
| 01/03/2008 | WO2008003013A2 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 01/03/2008 | WO2008002971A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/03/2008 | WO2008002924A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | WO2008002112A1 Method to inhibit cancer targeting cd24 |
| 01/03/2008 | WO2008002107A1 Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof |
| 01/03/2008 | WO2008001849A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/03/2008 | WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 01/03/2008 | WO2008001380A2 Method of treatment of age-related macular degeneration |
| 01/03/2008 | WO2008001370A2 Caspase-8 and inflammation, infection and wound healing |
| 01/03/2008 | WO2008001342A1 Recombinant staphylococcal phage lysin as an antibacterial agent |
| 01/03/2008 | WO2008001196A2 Contraceptive medicine comprising luteinizing hormone |
| 01/03/2008 | WO2008001175A2 Dipeptide compounds containing d-histidine |
| 01/03/2008 | WO2008001174A1 Peptide derivatives with therapeutic activity |
| 01/03/2008 | WO2008001113A2 Use of wnt5a for inhibiting scarring |
| 01/03/2008 | WO2008001045A1 Members of the glycoside hydrolase family 31 family of proteins |
| 01/03/2008 | WO2008000881A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 01/03/2008 | WO2008000870A1 Organic compounds that inhibit the catalytic activity of the cyclin-dependent cyclin a/kinase 2 complex by means of bonding thereof to a new pharmacophoric site in the cyclin molecule |
| 01/03/2008 | WO2008000803A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease |
| 01/03/2008 | WO2008000780A2 Inhalant powder containing phenylalanine |
| 01/03/2008 | WO2008000513A2 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | WO2008000490A1 High frequency application of neurotoxic component of botulinum toxin |
| 01/03/2008 | WO2008000447A1 New formulation for increasing bioavailability of neurturin |
| 01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2008000028A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/03/2008 | WO2007129093A3 Hla peptide therapy |
| 01/03/2008 | WO2007129077A3 Imaging agent |
| 01/03/2008 | WO2007128564A3 Use of a compound with rankl activity |
| 01/03/2008 | WO2007126455A3 Method for using boc/cdo to modulate hedgehog signaling |
| 01/03/2008 | WO2007126402A3 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 01/03/2008 | WO2007117467A3 Use of tm-601 for the diagnosis and treatment of tumors |
| 01/03/2008 | WO2007109750A3 Fermentation processes |
| 01/03/2008 | WO2007109605A3 Pharmaceutical compositions |
| 01/03/2008 | WO2007107328A8 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
| 01/03/2008 | WO2007089618A3 Hepatitis c serine protease inhibitors and uses therefor |
| 01/03/2008 | WO2007081419A3 Compositions and methods related to anti-fgf agents |
| 01/03/2008 | WO2007075845A3 Isolated mcpip and methods of use |
| 01/03/2008 | WO2007058879A3 Inhibitors of akt activity |
| 01/03/2008 | WO2007051077A3 Methods and compounds for lymphoma cell detection and isolation |
| 01/03/2008 | WO2007047763A3 Bcr-abl vaccines and methods of use thereof |
| 01/03/2008 | WO2006114308A8 Carrier for targeting nerve cells |
| 01/03/2008 | WO2005123116A3 Compositions and methods for treating or preventing oxalate-related disease |
| 01/03/2008 | WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |
| 01/03/2008 | WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 01/03/2008 | WO2003087335A3 Preservation of bioactive materials by spray drying |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | US20080004561 Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment |
| 01/03/2008 | US20080004435 Corticotropin releasing factor 2 receptor agonists |
| 01/03/2008 | US20080004434 prokaryotic host cells comprising a library of at least 103 different RNA molecules each having a dicistronic coding region; for screening a larger portion of the immunological repertoire for receptors having a preselected activity |
| 01/03/2008 | US20080004433 Characterization of the GSK-3beta protein and methods of use thereof |
| 01/03/2008 | US20080004432 HEMCM42 antibodies |
| 01/03/2008 | US20080004428 A neuregulin, epidermal growth factor, ligands for the ErbB/HER receptors; detecting EGFH2 polypeptides or mRNA for diagnostic and prognostic purposes; anticarcinogenic agents; antitumor agents; pancreatic cancer/tumor |
| 01/03/2008 | US20080004335 Athletic Ability Enhancing Composition |
| 01/03/2008 | US20080004311 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
| 01/03/2008 | US20080004225 New dialysis method |
| 01/03/2008 | US20080004224 Dermatological uses of tri-, tetra-, penta-, and polypeptides |
| 01/03/2008 | US20080004223 Dermatological uses of the tripeptide melanocyte stimulating inhibitory factor (mif) |
| 01/03/2008 | US20080004222 Antitumorigenic Drug Combination |
| 01/03/2008 | US20080004221 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides |
| 01/03/2008 | US20080004220 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2008 | US20080004219 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080004218 Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity |
| 01/03/2008 | US20080004217 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome (hadds) with or without lipodystrophy |
| 01/03/2008 | US20080004216 Modified vitamin K-dependent polypeptides |
| 01/03/2008 | US20080004215 Peptides and chemical compound for inhibition of SHP2 function |
| 01/03/2008 | US20080004214 Injectable collagen material |
| 01/03/2008 | US20080004213 Method of Inducing Melanogenesis in Humans With Mc1R Variant Alleles |
| 01/03/2008 | US20080004212 Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
| 01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
| 01/03/2008 | US20080004210 Diagnostic markers for ischemia |
| 01/03/2008 | US20080004209 Incubating resistin with a cathepsin, in the presence of a test compound; and measuring the level of proteolyzed resistin |
| 01/03/2008 | US20080004208 Methods for Diagnosis and Prognosis of Malignant Lymphoma |
| 01/03/2008 | US20080004207 Use of hmgb1 for protection against ischemia reperfusion injury |
| 01/03/2008 | US20080004206 Albumin fusion proteins |
| 01/03/2008 | US20080004205 Ultrafiltration membranes and methods of making |
| 01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003618 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a b-cell associated protein |
| 01/03/2008 | US20080003318 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003292 Nanoparticles and method for the production thereof |
| 01/03/2008 | US20080003288 Responsive microgel and methods related thereto |
| 01/03/2008 | US20080003272 flowable, containing thrombin, Factor XIII, fibrinogen, and a calcium salt; for wound healing in surgery, tissue therapy and/or as supporting material for biological factors; effervescent foams; biodegradable supports, bandages |
| 01/03/2008 | US20080003242 Botulinum toxin treatment for kinesia |